Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Harmaline (CAS No.: 304-21-2) is a natural alkaloid with significant biological activity and is an important member of the β-base alkaloid class. Its structural feature is that the Harman skeleton is replaced by a methoxy group at the C-7 position and is reduced at bonds 3 and 4, forming a unique molecular configuration. Camelbuck sinus is mainly found in various plants, especially species of the genus Peganum, and is one of the important components in traditional medicine. In recent years, with the rapid development of natural product pharmacology and molecular targeted therapy, Camelpamine has become one of the hotspots in anti-tumor drug development due to its multi-target regulatory capability and good druggability.

As a malignant tumor with a high incidence and mortality rate worldwide, gastric cancer still faces significant challenges in its treatment. Camel's multi-target regulatory effects in gastric cancer cells, especially its effects on key molecules such as BCL2, STAT3, NFE2L2, TOP1, MAPK1, PIK3CA, BCL2L1, MMP9, and EGFR, provide a theoretical basis for its anti-cancer potential. This article aims to systematically review the chemical structure, origin, pharmacological activity, and mechanism of action of Camelpagin, and, combined with druggability evaluation, explore its clinical prospects in diseases such as gastric cancer.

Chemical structure and physicochemical properties

Camel's pine has a molecular formula of C13H14N2O and a molecular weight of 214.2680, belonging to the β-base alkaloid class. Its structure is based on the Harman framework, with 3 and 4 bonds reduced and methoxy substitution at the C-7 position forming a unique substitution pattern. This structure gives camel tumbler good lipophile solubility (LogP=2.6638), making it easy to penetrate cell membranes and the blood-brain barrier (BBB has high permeability), which is beneficial for the pharmacological effects of the central nervous system.

In terms of physicochemical properties, Camelpamine has a polar surface area (TPSA) of 37.38 Ų, indicating moderate molecular polarity that facilitates penetration of biological membranes. Low water solubility (0.0340 mg/mL) suggests that in vivo it may require appropriate delivery carriers or formulation strategies to improve bioavailability. The hERG channel inhibition test was negative, indicating a low risk of cardiotoxicity. The Ames mutagenic test result was 0.3, indicating a low genotoxicity risk and a solid safety foundation.

Plant Origins and Extraction Methods

Peganum harmala (commonly known as Harman grass or Camel Mum) is mainly found in plants of the genus Peganum harmala. This plant is widely distributed across Central Asia, North Africa, and the Middle East, and has traditionally been used for antibacterial, anti-inflammatory, and neurological diseases. As one of its main active ingredients, Cameline undertakes multiple pharmacological functions.

The extraction method typically uses organic solvent extraction combined with acid-base extraction technology. The specific steps include: crushing dried plant seeds or whole plants, reflux extraction with ethanol or methanol, concentrating the filtrate, treating with dilute acid to dissolve the alkaloid into a salt state, and then adjusting the pH to precipitate in its free state. Further purification is performed by liquid-liquid extraction, column chromatography, or high-performance liquid chromatography (HPLC) to obtain high-purity Camelgrass alkaloids. In recent years, the application of ultrasound-assisted extraction and supercritical fluid extraction technologies has improved extraction efficiency and purity, reduced solvent usage, and aligned with the concept of green chemistry.

Pharmacological activity research

Cameline exhibits a variety of biological activities, covering anti-tumor, neuroprotection, antibacterial, and anti-inflammatory fields. Its antitumor activity is particularly outstanding, particularly in gastric cancer cell lines, showing remarkable cell proliferation inhibition and apoptosis-inducing effects.

Numerous in vitro studies have shown that camel bark alkaloids can effectively inhibit the proliferation of gastric cancer cells and induce cell cycle arrest and apoptosis. Its effects are closely related to regulating multiple signaling pathways, including inhibiting the STAT3 and MAPK signaling pathways, reducing the expression of anti-apoptotic proteins BCL2 and BCL2L1, and promoting the activation of apoptosis-related proteins. Additionally, camel bark alkaloid enhances cellular antioxidant capacity by regulating NFE2L2-mediated oxidative stress responses, reducing oxidative damage in the tumor microenvironment.

Animal model studies further confirmed the anti-tumor effects of camel tumblerine. Oral or injected camel puff sine can significantly inhibit the growth of gastric cancer grafted tumors, reduce tumor size and weight, and improve the pathological morphology of tumor tissue. Its antitumor mechanism involves inhibiting the invasion and metastasis capabilities of tumor cells, partially blocking extracellular matrix degradation by downregulating MMP9 expression, thereby suppressing tumor cell migration.

In addition to anti-tumor effects, camel bark alkaloids also show potential in neurological diseases. Its high blood-brain barrier penetration makes it a candidate drug for research on antidepressant, Parkinson's disease, and cognitive impairment. Camelberine exerts neuroprotective effects by regulating neurotransmitter metabolism and neuroprotective signaling pathways.

Mechanism of action and molecular targets

The pharmacological effects of camel bark pine are based on its multi-target regulatory capabilities, especially with significant progress in molecular mechanism studies in gastric cancer treatment. The main targets and mechanisms of action include:

1. BCL2 and BCL2L1
   Camel's bark alkaloid downregulates the expression of anti-apoptotic proteins BCL2 and BCL2L1, disrupting tumor cell survival signals and promoting mitochondrial pathway-mediated apoptosis. This mechanism is the core link in inducing apoptosis of gastric cancer cells.

2. STAT3 signaling pathway
   As an important regulatory factor for tumor cell proliferation and immune evasion, STAT3 blocks the expression of downstream pro-tumor genes by inhibiting phosphorylation activation, thereby suppressing tumor growth and metastasis.

3. NFE2L2 (NRF2) regulation
   Camelberine activates the NFE2L2 signaling pathway, enhancing cellular antioxidant defense, reducing oxidative stress damage, protecting normal cells from free radical damage, and regulating the tumor microenvironment.

4. TOP1 (Topoisomerase I)
   As a DNA topoisomerase, TOP1 plays a key role in DNA replication and transcription. Camelpine regulates TOP1 activity and may affect the DNA repair and proliferation capacity of tumor cells.

5. MAPK1 (ERK2) and PIK3CA (PI3K) signaling pathways
   Camelpineline regulates the MAPK and PI3K/AKT signaling pathways, inhibits tumor cell proliferation, promotes apoptosis, and influences cell cycle regulation.

6. MMP9 and EGFR
   Camelpine reduces matrix degradation by inhibiting matrix metalloproteinase MMP9 expression, thereby inhibiting tumor cell invasion and metastasis. At the same time, it regulates the EGFR signaling pathway and blocks tumor cell growth signaling.

In summary, camel aperine exerts its pharmacological effects against gastric cancer and other diseases through multi-target and multi-pathway synergistic effects, demonstrating promising potential for targeted therapy.

Druggability evaluation and pharmacokinetics

The druggability parameters of camel patrine indicate that it has good potential for drug development. A molecular weight of 214.2680 conforms to the Lipinski rule, and a LogP value of 2.6638 indicates moderate lipid solubility, which facilitates cell membrane penetration and oral absorption. The TPSA value of 37.38 Ų is relatively low, helping to penetrate biofilms and the blood-brain barrier, supporting its neurological pharmacological activity.

Low water solubility (0.0340 mg/mL) may limit oral bioavailability, and solubility is needed through pharmaceutical formulation technologies such as nanocarriers and solid dispersions. High blood-brain barrier permeability suggests it is suitable for treating central nervous system diseases, but potential CNS side effects should also be considered.

The hERG channel inhibition test was negative, reducing the risk of cardiotoxicity and offering good safety. The Ames test result was 0.3, indicating a low genotoxicity risk and meeting preclinical safety requirements.

Pharmacokinetic studies show that camel bark alkaloid is rapidly absorbed orally, has a moderate plasma half-life, and is widely distributed in the body, especially at high concentrations in brain tissue. Its metabolism is mainly through hepatic enzyme systems, and the safety of these metabolites still requires further evaluation. The excretion route is mainly in the kidneys, suggesting that renal function has a significant impact on drug clearance.

Prospects and outlooks for clinical applications

Camel's patriline, as a multi-target natural alkaloid, demonstrates broad pharmacological activity and good druggability, showing significant potential especially in the treatment of gastric cancer. By regulating multiple signaling pathways, it inhibits tumor cell proliferation, induces apoptosis, and blocks invasion and metastasis, providing new ideas for targeted treatment of gastric cancer.

The key to future clinical applications is to improve their bioavailability and targeting, thereby reducing potential toxic side effects. Nanodrug carriers, sustained-release formulations, and combination drug strategies are effective ways to enhance the clinical efficacy of camel aperine alkaloids. Moreover, in-depth study of its pharmacokinetic characteristics and metabolic mechanisms helps optimize dosing regimens and dosage design.

Besides stomach cancer, the prospects for Camelpine in neurological diseases, inflammation, and infectious diseases also deserve attention. Its high blood-brain barrier penetration and multi-target regulatory capability provide potential new drug candidates for treating neurodegenerative diseases and psychiatric disorders.

Overall, Camel's Phenokine, as a model for natural product drug development, is expected to become an effective treatment for various diseases through structural modification and drug design in the future. Strengthening its preclinical safety evaluation and mechanistic research will lay a solid foundation for its clinical translation.

Conclusion

Camel's pagin, as a natural alkaloid with a unique structure and diverse activity, has become a hot topic in research on gastric cancer and neurological diseases due to its multi-target regulatory capabilities and excellent druggability. By regulating key molecules such as BCL2, STAT3, NFE2L2, MAPK1, and PIK3CA, it exerts anti-tumor, antioxidant, and neuroprotective effects, demonstrating broad clinical application prospects.

Future research should focus on improving its pharmacokinetic performance, optimizing administration strategies, deeply analyzing mechanisms of action and safety evaluation, and promoting the translation of camel bark aline into clinical applications. As an important representative of natural product pharmacology, the development and application of camel tung alkaloid not only enrich natural drug resources but also provide new drug candidates and therapeutic approaches for modern precision medicine.